Literature DB >> 3494744

Immunospecific T-lymphocyte stimulation by membrane proteins from Francisella tularensis.

G Sandström, A Tärnvik, H Wolf-Watz.   

Abstract

Membranes from a capsule-deficient mutant of the live-vaccine strain of Francisella tularensis (F. tularensis LVS) were treated with N-lauroyl sarcosinate (Sarkosyl; CIBA-GEIGY Corp., Summit, N.J.). When the Sarkosyl-insoluble fraction was heated in the presence of sodium dodecyl sulfate and mercaptoethanol and subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis, several polypeptides were distinguished. Four major polypeptides were eluted from the gel, each of which stimulated lymphocytes from tularemia-vaccinated individuals but not from nonvaccinated individuals. The stimulation occurred mainly in T lymphocytes. Radioactive labeling of surface proteins of the capsule-deficient bacteria indicated that at least two of the four polypeptides originated from outer membrane proteins. The results suggest that several membrane proteins of F. tularensis LVS induce a specific T-lymphocyte response.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3494744      PMCID: PMC266051          DOI: 10.1128/jcm.25.4.641-644.1987

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  17 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Subunit structure of functional porin oligomers that form permeability channels in the other membrane of Escherichia coli.

Authors:  T Nakae; J Ishii; M Tokunaga
Journal:  J Biol Chem       Date:  1979-03-10       Impact factor: 5.157

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Stimulation of subpopulations of human lymphocytes by a vaccine strain of Francisella tularensis.

Authors:  A Tärnvik; S E Holm
Journal:  Infect Immun       Date:  1978-06       Impact factor: 3.441

5.  Elution of proteins from sodium dodecyl sulfate-polyacrylamide gels, removal of sodium dodecyl sulfate, and renaturation of enzymatic activity: results with sigma subunit of Escherichia coli RNA polymerase, wheat germ DNA topoisomerase, and other enzymes.

Authors:  D A Hager; R R Burgess
Journal:  Anal Biochem       Date:  1980-11-15       Impact factor: 3.365

6.  Tularaemia in the rat. I. The cellular basis on host resistance to infection.

Authors:  A A Kostiala; D D McGregor; P S Logie
Journal:  Immunology       Date:  1975-05       Impact factor: 7.397

7.  Stimulation of human lymphocytes by a vaccine strain of Francisella tularensis.

Authors:  A Tärnvik; S Löfgren
Journal:  Infect Immun       Date:  1975-11       Impact factor: 3.441

8.  Disulfide-linked oligomers of the major outer membrane protein of chlamydiae.

Authors:  W J Newhall; R B Jones
Journal:  J Bacteriol       Date:  1983-05       Impact factor: 3.490

9.  Time of lymphocyte response after onset of tularemia and after tularemia vaccination.

Authors:  A Tärnvik; G Sandström; S Löfgren
Journal:  J Clin Microbiol       Date:  1979-12       Impact factor: 5.948

10.  Virulence factors of Francisella tularensis.

Authors:  A M Hood
Journal:  J Hyg (Lond)       Date:  1977-08
View more
  29 in total

Review 1.  Francisella tularensis--a model for studies of the immune response to intracellular bacteria in man.

Authors:  A Tärnvik; M Eriksson; G Sandström; A Sjöstedt
Journal:  Immunology       Date:  1992-07       Impact factor: 7.397

2.  Protective immunity against tularemia provided by an adenovirus-vectored vaccine expressing Tul4 of Francisella tularensis.

Authors:  Ravinder Kaur; Shan Chen; Maria T Arévalo; Qingfu Xu; Yanping Chen; Mingtao Zeng
Journal:  Clin Vaccine Immunol       Date:  2012-01-25

3.  Characterization of Francisella tularensis outer membrane proteins.

Authors:  Jason F Huntley; Patrick G Conley; Kayla E Hagman; Michael V Norgard
Journal:  J Bacteriol       Date:  2006-11-17       Impact factor: 3.490

4.  Cell-mediated and humoral immune responses after vaccination of human volunteers with the live vaccine strain of Francisella tularensis.

Authors:  D M Waag; K T McKee; G Sandstrom; L L Pratt; C R Bolt; M J England; G O Nelson; J C Williams
Journal:  Clin Diagn Lab Immunol       Date:  1995-03

5.  Protein heterogeneity of Francisella tularensis: detection of proteins with antigenic determinants.

Authors:  J Stulik; J Cerna; H Kovarová; A Macela
Journal:  Folia Microbiol (Praha)       Date:  1989       Impact factor: 2.099

6.  Several membrane polypeptides of the live vaccine strain Francisella tularensis LVS stimulate T cells from naturally infected individuals.

Authors:  A Sjöstedt; G Sandström; A Tärnvik
Journal:  J Clin Microbiol       Date:  1990-01       Impact factor: 5.948

7.  Various membrane proteins of Francisella tularensis induce interferon-gamma production in both CD4+ and CD8+ T cells of primed humans.

Authors:  A Sjöstedt; M Eriksson; G Sandström; A Tärnvik
Journal:  Immunology       Date:  1992-08       Impact factor: 7.397

Review 8.  Working toward the future: insights into Francisella tularensis pathogenesis and vaccine development.

Authors:  Roger D Pechous; Travis R McCarthy; Thomas C Zahrt
Journal:  Microbiol Mol Biol Rev       Date:  2009-12       Impact factor: 11.056

9.  TLR4-mediated activation of dendritic cells by the heat shock protein DnaK from Francisella tularensis.

Authors:  Amit R Ashtekar; Ping Zhang; Jannet Katz; Champion C S Deivanayagam; Prasad Rallabhandi; Stefanie N Vogel; Suzanne M Michalek
Journal:  J Leukoc Biol       Date:  2008-08-15       Impact factor: 4.962

10.  Cell-mediated and humoral immune responses induced by scarification vaccination of human volunteers with a new lot of the live vaccine strain of Francisella tularensis.

Authors:  D M Waag; A Galloway; G Sandstrom; C R Bolt; M J England; G O Nelson; J C Williams
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.